Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19

Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19

There is limited evidence describing the safety and effectiveness of bedaquiline and delamanid containing regimens in children and adolescents with Multidrug-Resistant Tuberculosis (MDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) globally. In this nationwide descriptive cohort study fr...

Full description

Bibliographic Details
Main Authors: Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina
Format: Article
Language:English
Published: PAGEPress Publications 2021-01-01
Series:Monaldi Archives for Chest Disease
Subjects:
new anti-tuberculosis drugs
fluoroquinolone resistance
rifampicin resistance
second-line injectable drug resistance
adverse drug safety monitoring
Online Access:https://monaldi-archives.org/index.php/macd/article/view/1646

Internet

https://monaldi-archives.org/index.php/macd/article/view/1646

Similar Items